Since 1993, the company has provided customer-oriented pharma services from product development through post-marketing monitoring, focusing on selecting the right product and developing effective design and marketing for successful partnerships. Its market analysis, product development, regulatory affairs, pharmacovigilance, batch release, logistics and marketing services help partners bring products into the Lithuanian and Baltic States markets. On January 8, 2024, Corpus Medica and its subsidiaries changed their name to Eletis Medica.
No hay comentarios disponibles.
Deja tu valoración & comentario